Senate backs prostate cancer awareness month—a public health win
S.Res. 436 — A resolution expressing support for the designation of September 2025 as "National Prostate Cancer Awareness Month". · Filed by Mike Crapo (R-ID) · 3 cosponsors · Introduced Oct 6, 2025 · Passed chamber
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This is a Senate resolution expressing support for designating September 2025 as 'National Prostate Cancer Awareness Month.' It documents the scale of prostate cancer in the U.S. (3.3 million men living with it, 1 in 8 lifetime diagnosis risk), notes federal research funding ($7.2 billion to the National Cancer Institute, $75 million to the Defense Department's Prostate Cancer Research Program), and calls on Americans, health organizations, and government to raise awareness about screening and treatment.
Why we flagged it
This is a non-binding commemorative resolution that designates a month for public awareness of a significant health condition. It contains no legislative mechanism, appropriations, or regulatory change—only a call for awareness and continued research support.
What the text implies
- Implicit endorsement of prostate cancer screening may influence clinical practice and patient demand, potentially increasing screening volume and associated healthcare costs (both diagnostic and treatment-related).
- Resolution cites specific federal funding levels ($7.2B to NCI, $75M to DoD program), which may signal congressional intent to maintain or increase these appropriations in future budget cycles.
The full analysis lists 3 implications of this text.
Who stands to gain
pharmaceutical companies (cancer treatment drugs); medical device manufacturers (diagnostic and treatment equipment); healthcare providers and hospital systems (screening and treatment services)